Clinical Trial Update: Efficacy and Safety of Parecoxib vs. Indomethacin in Preventing Post-ERCP Pancreatitis [Phase 2]

View source ↗

Summary

Phase 2 trial comparing parecoxib vs indomethacin for prevention of post-ERCP pancreatitis; currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatitis
• Postendoscopic Retrograde Cholangiopancreatography Pancreatitis

Drugs mentioned

• Dynastat
• INDOCIN (INDOMETHACIN)

Snippet

Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: Pancreatitis, Acute, Cholangiopancreatography, Endoscopic Retrograde | Phase 2 | Status: NOT_YET_RECRUITING